Request Deal Involvement
RTW Investments-backed SPAV to acquire and merge with Immunovant in a $395m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Chardan
legal advisors
Loeb & Loeb
legal advisors
Cooley
financial advisors
Leerink Partners
or
Principals
bidder
RTW INVESTMENTS
target
IMMUNOVANT SCIENCES LTD
bidder
HEALTH SCIENCES ACQUISITION CORP
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite